| Literature DB >> 32456077 |
Mariana I C Raposo1, Maria Teresa S R Gomes1, Maria João Botelho2,3, Alisa Rudnitskaya1.
Abstract
Paralytic shellfish toxins (PSTs) are a group of toxins that cause paralytic shellfish poisoning through blockage of voltage-gated sodium channels. PSTs are produced by prokaryotic freshwater cyanobacteria and eukaryotic marine dinoflagellates. Proliferation of toxic algae species can lead to harmful algal blooms, during which seafood accumulate high levels of PSTs, posing a health threat to consumers. The existence of PST-transforming enzymes was first remarked due to the divergence of PST profiles and concentrations between contaminated bivalves and toxigenic organisms. Later, several enzymes involved in PST transformation, synthesis and elimination have been identified. The knowledge of PST-transforming enzymes is necessary for understanding the processes of toxin accumulation and depuration in mollusk bivalves. Furthermore, PST-transforming enzymes facilitate the obtainment of pure analogues of toxins as in natural sources they are present in a mixture. Pure compounds are of interest for the development of drug candidates and as analytical reference materials. PST-transforming enzymes can also be employed for the development of analytical tools for toxin detection. This review summarizes the PST-transforming enzymes identified so far in living organisms from bacteria to humans, with special emphasis on bivalves, cyanobacteria and dinoflagellates, and discusses enzymes' biological functions and potential practical applications.Entities:
Keywords: biotransformation; carbamoylase; enzyme; paralytic shellfish toxins; sulfotransferase
Mesh:
Substances:
Year: 2020 PMID: 32456077 PMCID: PMC7290730 DOI: 10.3390/toxins12050344
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Structure of paralytic shellfish toxins and correspondent TEF (toxicity equivalency factor) [4], toxicity obtained by mouse bioassay (MBA) relative to STX [6,13,14] or dissociation constant KD characterizing the potency of binding to rat brain sodium channels KD (nM) [15,16] for compounds for which TEF is not defined. STX—saxitoxin, GTX—gonyautoxin.
|
| Basic Structure | |||||||
|
|
|
|
|
|
|
|
|
|
| Carbamoyl | STX | H | H | H |
| 1.0 | 1.0 | 0.5 |
| NeoSTX | OH | H | H | 1.0 | ||||
| GTX1 | OH | H | OSO−3 | 1.0 | ||||
| GTX2 | H | H | OSO−3 | 0.4 | ||||
| GTX3 | H | OSO−3 | H | 0.6 | ||||
| GTX4 | OH | OSO−3 | H | 0.7 | ||||
| M2 | H | OH | H | nk | ||||
| M4 | H | OH | OH | |||||
| Decarbamoyl (dc) | dcSTX | H | H | H |
| 1.0 | ||
| dcNeoSTX | OH | H | H | 0.4 | ||||
| dcGTX1 | OH | H | OSO−3 | 0.5 | ||||
| dcGTX2 | H | H | OSO−3 | 0.2 | ||||
| dcGTX3 | H | OSO−3 | H | 0.4 | ||||
| dcGTX4 | OH | OSO−3 | H | 0.5 | ||||
| ▪ LWTX4 | H | H | H | 0.004 | ||||
| N-sulfocarbamoyl | GTX5 (B1) | H | H | H |
| 0.1 | ||
| GTX6 (B2) | OH | H | H | 0.1 | ||||
| C1 | H | H | OSO−3 | 0.02 | ||||
| C2 | H | OSO−3 | H | 0.1 | ||||
| C3 | OH | H | OSO−3 | 0.01 | ||||
| C4 | OH | OSO−3 | H | 0.1 | ||||
| M1 | H | OH | H | nk | ||||
| M3 | H | OH | OH | |||||
| Mono-hydroxybenzoate | GC1 | H | H | OSO−3 |
| 3.4–4.4 | ||
| GC2 | H | OSO−3 | H | 3.4–4.4 | ||||
| GC3 | H | H | H | 2.2 | ||||
| *GC4 | OH | H | OSO−3 | nk | ||||
| *GC5 | OH | OSO−3 | H | |||||
| *GC6 | OH | H | H | |||||
| Di-hydroxybenzoate | #GC1a | H | H | OSO−3 | Di-hydroxy-benzoate analogue | nk | ||
| #GC2a | H | OSO−3 | H | |||||
| #GC3a | H | H | H | |||||
| #GC4a | OH | H | OSO−3 | |||||
| #GC5a | OH | OSO−3 | H | |||||
| #GC6a | OH | H | H | |||||
| Sulfated-benzoate | #GC1b | H | H | OSO−3 | Sulfated-benzoate-analogue | nk | ||
| #GC2b | H | OSO−3 | H | |||||
| #GC3b | H | H | H | |||||
| #GC4b | OH | H | OSO−3 | |||||
| #GC5b | OH | OSO−3 | H | |||||
| #GC6b | OH | H | H | |||||
| Deoxydecarbamoyl (do) | doSTX | H | H | H | CH3 | nk | ||
| doGTX2 | H | H | OSO−3 | |||||
| doGTX3 | H | OSO−3 | H | |||||
| Acetate | ▪ LWTX1 | H | H | OSO−3 |
| 0.07 | ||
| LWTX2 | H | H | OSO−3 | 0.004 | ||||
| LWTX3 | H | OSO−3 | H | 0.02 | ||||
| LWTX5 | H | H | H | 0.14 | ||||
| ▪ LWTX6 | H | H | H | 0.004 | ||||
* Not structurally characterized; # R4 group not structurally characterized; ▪12-deoxy compounds; nk = not known.
Characteristics of sulfotransferases (N-ST and O-ST) from several dinoflagellate species.
| ST Type | N-ST | O-ST | ||
|---|---|---|---|---|
| Dinoflagellate species |
|
|
|
|
| Optimal activity pH | 6 | 6 | 6 | 6 |
| Optimal activity temperature | 25 °C | 15 °C | 15 °C | 35 °C |
| Molecular mass | 59 kDa | 60 kDa | nk | 65 kDa |
| Structure | monomeric | nk | nk | monomeric |
| Cation requirement | Mg2+, Co2+ | none | none | none |
| Sulfate Donor | PAPS | PAPS | PAPS, DMSO, MgSO4 | PAPS |
| Reactions | GTX2+3 → C1+2 | GTX2+3 → C1+2 | GTX2+3 → C1+2 | 11-α,β-hydroxy STX → GTX2+3 |
nk—not known, PAPS—3′-phosphate-5′-phosphosulfate.
Enzymes or enzymatic-mediated transformations present in different species.
| Enzyme/Enzymatic Mediated Transformations | Organism | References |
|---|---|---|
| Carbamoylase |
| [ |
|
| [ | |
|
| [ | |
|
| [ | |
|
| [ | |
|
| [ | |
|
| [ | |
|
| [ | |
|
| [ | |
|
| [ | |
|
| [ | |
|
| [ | |
|
| [ | |
|
| [ | |
|
| [ | |
|
| [ | |
|
| [ | |
|
| [ | |
|
| [ | |
|
| [ | |
|
| [ | |
|
| [ | |
|
| [ | |
| [ | ||
| Humans | [ | |
| Sulfocarbamoylase |
| [ |
|
| [ | |
|
| [ | |
| N-sulfotransferase-PST synthesis |
| [ |
|
| [ | |
|
| [ | |
| [ | ||
| [ | ||
|
| [ | |
| [ | ||
|
| [ | |
|
| [ | |
| O-sulfotransferase-PST synthesis |
| [ |
| [ | ||
| [ | ||
|
| [ | |
| [ | ||
|
| [ | |
|
| [ | |
| N-sulfotransferase-PST metabolism |
| [ |
|
| [ | |
|
| [ | |
|
| [ | |
|
| [ | |
|
| [ | |
|
| [ | |
| [ | ||
| Rieske oxygenases |
| [ |
| Reduction at N1 position |
| [ |
|
| [ | |
|
| [ | |
|
| [ | |
| Bacteria (isolated from | [ | |
| [ | ||
| α- and γ-Proteobacteria (isolated from dinoflagellates) | [ | |
| Oxidation at N1 position |
| [ |
| [ | ||
| [ | ||
|
| [ | |
| [ | ||
| Humans | [ | |
| Glutathione-S-transferase |
| [ |
|
| [ | |
| Glucuronosyltransferases | Humans | [ |
* Conversion of benzoate paralytic shellfish toxins (PSTs).
Figure 1Enzymatic transformations of paralytic shellfish toxins (PSTs) catalyzed by carabamoylase I and sulfocarbamoylase I.
Figure 2Enzymatic transformations among paralytic shellfish toxins (PSTs) occurring in bivalves, dinoflagellates, fish and humans.